SCHEMBL29629596

SCHEMBL29629596

Oc1ccc(Cl)cc1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL91153 1.00
SCHEMBL28686760 0.97 ALOX15 (0.54)
SCHEMBL28700548 0.97 ALOX15 (0.54)
SCHEMBL28708943 0.97 ALOX15 (0.54)
SCHEMBL28936596 0.85 HSD17B10 (0.48)
SCHEMBL15674635 0.81 ALOX5 (0.65)
SCHEMBL897593 0.79
SCHEMBL25876566 0.77 THRA (0.50)
SCHEMBL8633861 0.77 MAOA (0.44)
SCHEMBL25408639 0.75 HSD17B10 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117736156-A Organic compound, organic light emitting diode including the same, and display device including the organic light emitting diode 秀博瑞殷株式公社 2024-03-22 CN disclosed
EP-4291571-A2 ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A HEAT SHOCK PROTEIN 90 BINDING DOMAIN Seattle Children's Hospital d/b/a Seattle Children's Research Institute (US) 2023-12-20 EP disclosed
EP-4185592-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF Annexon, Inc. (US) 2023-05-31 EP disclosed
WO-2022174035-A2 ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A HEAT SHOCK PROTEIN 90 BINDING DOMAIN SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE (US) 2022-08-18 WO disclosed
EP-3994126-A1 PROCESS FOR THE PREPARATION OF KEY INTERMEDIATES FOR THE SYNTHESIS OF ELTROMBOPAG OR SALT THEREOF F.I.S.- Fabbrica Italiana Sintetici S.p.A. (IT) 2022-05-11 EP disclosed